UPDATE: Goldman Sachs Assumes Neurocrine Bio. (NBIX) at Neutral
Tweet Send to a Friend
(Updated - May 18, 2021 6:49 AM EDT)
Goldman Sachs analyst Chris Shibutani assumes coverage on Neurocrine Bio. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani assumes coverage on Neurocrine Bio. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
